Anavex Life Sciences Corp. · BX:12X1

Anavex Life Sciences Corp. financial statements

Anavex Life Sciences Corp.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Research and development37.6M41.8M43.7M37.9M33.0M25.2M22.3M13.3M10.7M7.25M
Selling, general and administrative13.8M11.0M12.0M
Operating income-51.4M-52.9M-55.8M-51.0M-42.0M-31.1M
Depreciation and amortization1.25K
Income before tax-46.4M-43.0M-47.5M-47.6M-37.6M-26.3M-26.2M-17.2M-13.4M-14.7M
Net income-46.4M-43.0M-47.5M-48.0M-37.9M-26.3M-26.3M-17.3M-13.5M-14.7M
Earnings per share, basic-0.54-0.52-0.60-0.62-0.54-0.45-0.54-0.39-0.33-0.42
Earnings per share, diluted-0.54-0.52-0.60-0.62-0.54-0.45-0.54-0.39-0.33-0.42

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents102.6M132.2M151.0M149.2M152.1M29.2M22.2M22.9M27.4M9.19M
Current assets25.3M26.1M27.8M9.45M
Total assets103.8M135.6M154.4M152.7M161.6M34.5M25.3M26.2M27.8M9.50M
Accounts payable4.25M9.63M4.32M3.83M4.74M3.99M3.52M2.96M
Current liabilities10.8M7.31M5.04M3.88M3.58M3.19M
Total liabilities8.95M15.3M12.5M10.2M10.8M7.31M5.04M3.58M3.19M
Shareholders' equity94.9M120.3M141.9M142.5M150.8M27.2M20.3M22.3M25.9M6.31M
Shares outstanding86.7M84.8M82.1M77.9M75.9M62.0M52.7M45.9M43.3M36.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-39.0M-30.8M-27.8M-24.2M-30.4M-21.3M-18.5M-12.6M-9.02M-9.24M
Cash from financing9.43M12.0M29.7M21.3M153.2M28.4M17.8M8.07M27.3M3.13M
Change in cash-29.6M-18.8M1.87M-2.95M122.9M7.06M-745.0K